James Harris is professor of psychiatry and behavioral sciences at Johns Hopkins University School of Medicine in Baltimore, where he is founding director of the Developmental Neuropsychiatry Clinic. He is also a professor at Johns Hopkins Bloomberg School of Public Health. He served on the American Psychiatric Association committee that wrote the new definition of autism spectrum disorder for the DSM-5.
James Harris
Professor of psychiatry and behavioral sciences
Johns Hopkins University School of Medicine
From this contributor
Correcting the record: Leo Kanner and the broad autism phenotype
The specter of the ‘refrigerator mother’ theory continues to haunt the history of autism. New information puts Kanner’s observations of parents into context.
Correcting the record: Leo Kanner and the broad autism phenotype
By
James Harris, Joseph Piven
26 April 2016 | 10 min read
Explore more from The Transmitter
NIH neurodevelopmental assessment system now available as iPad app
Here is a roundup of autism-related news and research spotted around the web for the week of 24 March.
NIH neurodevelopmental assessment system now available as iPad app
Here is a roundup of autism-related news and research spotted around the web for the week of 24 March.
By
Jill Adams
25 March 2025 | 2 min read
Keep sex as a biological variable: Don’t let NIH upheaval turn back the clock on scientific rigor
Even in the absence of any formal instruction to do so, we should continue to hold our ourselves and our neuroscience colleagues accountable for SABV practices.
Keep sex as a biological variable: Don’t let NIH upheaval turn back the clock on scientific rigor
Even in the absence of any formal instruction to do so, we should continue to hold our ourselves and our neuroscience colleagues accountable for SABV practices.
By
Rebecca Shansky
25 March 2025 | 7 min read
Single-cell genomics technologies and cell atlases have ushered in a new era of human neurobiology
Single-cell approaches are already shedding light on the human brain, identifying cell types that are most vulnerable in the early stages of Alzheimer’s disease, for example.
Single-cell genomics technologies and cell atlases have ushered in a new era of human neurobiology
Single-cell approaches are already shedding light on the human brain, identifying cell types that are most vulnerable in the early stages of Alzheimer’s disease, for example.
By
Ed Lein, Hongkui Zeng
24 March 2025 | 7 min read